Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05145738 · ClinicalTrials.gov registry record · NA

Pilot Testing a Computer Delivered Tobacco Cessation Intervention in Outpatient Clinical Settings: A Feasibility Study

A NA study of Tobacco Smoking, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT05145738: Completed NA study of Tobacco Smoking, sponsored by Johns Hopkins University.

NCT05145738 is a NA study of Tobacco Smoking that has completed, run by Johns Hopkins University. The registered enrollment target is 18 participants, below the 477-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05145738, a NA study of Tobacco Smoking, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The investigators have developed a hybrid computer- and person-delivered intervention, called "C-Raven" for smoking cessation that is tailored to people with tobacco use in Baltimore City. The computer delivered component consists of two \~20 minute sessions on an iPad guided by Edna Poe, an interactive avatar. These sessions are followed by elective in vivo initiation of nicotine replacement therapy (NRT). Community health workers (CHWs) trained in smoking cessation and motivational interviewing provide 6 weeks of supportive follow up counseling. The investigators propose a pilot of the intervention package in the Tobacco Treatment and Lung Cancer Screening Clinic (TTLCSC) at Johns Hopkins Hospital, and the Johns Hopkins Broadway Center for Addiction, assessing feasibility and acceptability of using this tool in these clinical settings. In addition, the investigators will compare whether the use of a virtual counselor is associated with greater satisfaction and engagement with the program. To this end, the investigators propose a two-arm randomized controlled trial, randomizing up to 90 individuals with tobacco use to the current CRAVEN program which includes a virtual counselor, to CRAVEN without a virtual counselor. Primary outcomes include intervention feasibility and acceptability. The investigators will secondarily examine uptake and maintenance of pharmacotherapy for tobacco cessation, readiness to quit smoking, and tobacco cessation (7 day abstinence) at 6 months, patient satisfaction by intervention arm and CHW engagement by intervention arm.

Primary Outcome

Feasibility will be assessed with percent of persons agreeing to participate among those referred.

Conditions Studied

Interventions

  • BEHAVIORAL C-Raven with avatar
  • BEHAVIORAL C-Raven without avatar

Study Locations (1)

Maryland

  • Johns Hopkins Tobacco Treatment Clinic at Johns Hopkins Bayview Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2021-12-23
Est. Completion 2022-09-15
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT05145738 record still lists

NCT05145738 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 477-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Tobacco Smoking appearing as the primary indexed condition, and to 2 interventions - of which C-Raven with avatar is the first listed.

NCT05145738 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05145738 about?

NCT05145738 is a clinical study titled "Pilot Testing a Computer Delivered Tobacco Cessation Intervention in Outpatient Clinical Settings: A Feasibility Study". The investigators have developed a hybrid computer- and person-delivered intervention, called "C-Raven" for smoking cessation that is tailored to people with tobacco use in Baltimore City. The computer delivered component consists of two \~20 minute sessions on an iPad guided by Edna Poe, an interac...

What is the current status of trial NCT05145738?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2021-12-23. Estimated completion is 2022-09-15.

What conditions does trial NCT05145738 study?

This clinical trial studies the following conditions: Tobacco Smoking.

What interventions are being tested in trial NCT05145738?

The interventions under investigation include: C-Raven with avatar (BEHAVIORAL), C-Raven without avatar (BEHAVIORAL).

Who is sponsoring clinical trial NCT05145738?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05145738 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05145738's enrollment target sits among peer trials

18 34th of 38 higher than 5 of 38 other Tobacco Smoking trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05145738, the US trial registry maintained by the National Library of Medicine. NCT05145738 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.